If we add this small up front payment to the the Strides deal, and the balance of the R&D tax rebate, and the ongoing development funding for 001H, it seems to me we could be close to cash flow positive for the quarter. This is in itself is welcome news, and if that's how it pans out, will lift the share price when the quarterly is released. I would be most surprised if Zelda were paying even as much as as $100,000 per quarter for the lab development. However we should not overlook the fact that even a small contribution adds more revenue to the coffers and decreases our overhead. I think there are certainly strong grounds to be optimistic of further revenue from Zolpimist and the big sleeper(Artimist). Things are shaping up nicely!
SUD Price at posting:
0.5¢ Sentiment: Hold Disclosure: Held
